Upload a complaint or brief to quickly find on-point case law.
CARA A.I. uses the facts and legal issues in your document to find relevant authorities.
Drag a complaint or brief hereUpload a complaint or briefPDF documentWORD documentTXT documentOr, choose a document to uploadChoose DocumentSecure
Find on-point cases faster with CARA A.I.
§

Allergan, Inc. v. Sandoz Inc.

726 F.3d 1286 (Fed. Cir. 2013)
Depth of Treatment
Newest to Oldest
Oldest to Newest
Cite Count
Allergan, Inc. v. Sandoz Inc.

1 Citing case

  1. Infineum U.S. L.P. v. Chevron Oronite Co.

    No. 2020-1333 (Fed. Cir. Aug. 8, 2022)

    . Relying on Allergan, Inc. v. Sandoz Inc., 726 F.3d 1286, 1293 (Fed. Cir. 2013), the Board concluded that Infineum's unexpected results evidence was not meaningful in view of the fact that Toshikazu "provide[d] a strong reason to use low levels of molybdenum in combination with an organic ashless nitrogen-free friction modifier." Decision, 2019 WL 5806946, at *14.